Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
55,981,344
-
Share change
-
+3,503,655
-
Total reported value
-
$9,856,454,549
-
Put/Call ratio
-
269%
-
Price per share
-
$176.07
-
Number of holders
-
367
-
Value change
-
+$619,952,018
-
Number of buys
-
166
-
Number of sells
-
174
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2015
As of 30 Jun 2015,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
367 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,981,344 shares.
The largest 10 holders included
FMR LLC, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, Westpac Banking Corp, JANUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and Bank of New York Mellon Corp.
This page lists
367
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.